Novo Holdings, a prominent Danish investment firm with a focus on life sciences, has recently cemented its standing in the biopharma manufacturing industry through a strategic acquisition. Securing a majority stake in Single Use Support, Novo Holdings ventures further into an increasingly vital
The biotech industry is poised for transformative growth, fueled by scientific breakthroughs and the application of cutting-edge technologies. In this nexus of innovation, 21st.BIO stands out with its recent announcement of a new pilot plant in the heart of Europe's biotech landscape. This
ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position
BioNTech, the German biotechnology company known for its pivotal role in creating a COVID-19 vaccine with Pfizer, has inaugurated a state-of-the-art modular mRNA vaccine production facility in Kigali, the capital of Rwanda. This initiative marks a significant step toward health equality and local
Under the insightful leadership of executives like Raje, LGM Pharma has experienced significant evolution since being acquired by New Harbour Capital Private Equity. Initially, LGM Pharma was primarily focused on supply chain logistics within the pharmaceutical industry. However, it has since
Upstream bioprocessing is pivotal in biomanufacturing, where cellular systems produce vital therapeutic proteins and biological products. This field is experiencing a surge of innovative methods in response to the increased global demand for biopharmaceuticals driven by rising health concerns.
